It's a Wrap! Pharma-Biotech Industry Set To Complete 268 North American CAPEX/MRO Projects, $6 Billion in Investments in Third-Quarter 2016
It's a Wrap! Pharma-Biotech Industry Set To Complete 268 North American CAPEX/MRO Projects, $6 Billion in Investments in Third-Quarter 2016
Attachment: pharma
SUGAR LAND--August 23, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--By the end of the third quarter of 2016, the Pharmaceutical-Biotech industry is expected to complete construction on a total of 268 North American capital and MRO (maintenance, repair and operations) projects. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Database reveals that the projects represent a total investment value (TIV) of $5.92 billion.
Within this article: Lists three pharmaceutical projects that Industrial Info is tracking
Additional companies: Gilead Sciences (NASDAQ:GILD)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- California Gears Up for $3.9 Billion in Third-Quarter Project Completions
- Whiting-Turner's 10 Top-Valued Projects Point to Growing Role in Pharma, Fo...
- Pharma-Biotech Capital Construction 2015 Investment Review: $15 Billion in ...
- Nanotherapeutics Nears Home Stretch for Department of Defense's $150 Millio...
- Golden State Delivers on its Name: Life-Science Sector to Invest $2.5 Billi...